|
市場調査レポート
商品コード
1166511
スライドステイナーの世界市場-2022-2029Global Slide Stainer Market - 2022-2029 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
スライドステイナーの世界市場-2022-2029 |
出版日: 2022年11月30日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
|
スライドステイナーの世界市場規模は、2021年に37億420万米ドルを表し、予測期間(2022-2029年)にはCAGR11%で推移しています。
ステイナーは、組織や細胞を分離し、顕微鏡検査や識別を行うために使用されます。スライドステイナーは、直接染色、間接染色、表面吸着染色、媒染剤染色により、試料に色素を拡散させ、準備した細胞診や組織診の試料を自動的に染色するものです。自動染色機には、回転搬送と直進搬送の2つの工程があります。
スライドステイナーの世界市場の成長は、慢性疾患や感染症の有病率の上昇、技術の進歩、診断や臨床研究における自動化の需要の高まりが、市場成長を促進する重要な要因となっています。
慢性疾患の有病率の増加が予測期間中の成長を促進する見込み
慢性疾患や生命を脅かす疾患の増加により、製薬会社や研究会社は効果的な治療法を開発するために研究開発活動に注力しています。ラボ機器の自動化における進歩により、スライドステイナーは病気の診断や腫瘍の研究に応用されるようになりました。
国際糖尿病連合によると、2019年に糖尿病患者は7600億米ドルを費やし、そのうちほとんどが1型糖尿病患者がインスリン製剤に費やしています。現在、約4億6300万人の成人(20~79歳)が糖尿病を患っており、2045年には7億人に増加すると予測されています。ほとんどの国で2型糖尿病患者の割合が増加しています。また、米国心臓協会によると、2015年には米国人口の約41.5%が何らかの心疾患を患っており、さらにこの有病率は2035年までに45%に増加すると推測されています。米国の疾病管理予防センター(CDC)によると、米国の人口の約半数(47%)がこれら3つの危険因子のうち少なくとも1つを有しているとされています。米国国立がん研究所によると、最も多いがんは、前立腺がん、乳がん、肺がんおよび気管支がん、結腸・直腸がん、皮膚のメラノーマ、膀胱がん、非ホジキンリンパ腫、腎臓・腎盂がん、内膜がん、白血病、膵臓がん、甲状腺がん、肝臓がんであるとのことです。
したがって、慢性疾患や感染症による健康被害が拡大していることが、特に先進国においてスライドステインダーの需要を高める主な要因となっています。新興国においては、感染症の流行により国民の定期健康診断への支出が増加しており、病院などのヘルスケアプロバイダーがラボプロセスの自動化を推進するようになっています。このため、高性能なスライドステイナーの需要が高まっています。
自動スライドステイナーに関連する懸念が市場成長の妨げになる可能性が高い
自動染色機の使用には、初期費用、スペースの確保、修理の問題など、いくつかの懸念があり、スライドステイナーの採用が遅れています。ルーチンステイナーにはバックアップとして手動方式しかない場合もあるが、ラボで手動ステインシステムが収まる唯一のスペースをステイナーが占有している場合もあります。
発展途上国で専門技術者が不足しているサービス技術者の場合、修理のためのダウンタイムが長くなります。一部のシステムで必要とされる専用試薬に制限されることに反対する技師もいます。
もう一つの懸念は、検査技師が染色プロセスから外れることです。手作業で染色する場合、技師は各ステップを観察することができます。もし何か問題があると感じたら、その手順を中断して問題を修正することができる場合が多いです。
自動化されたシステムでの染色問題は、完成品を確認するまで気づかないことがあり、この段階でのトラブルシューティングが困難な場合があります。トレーニングの場面では、染色の原理を学ぶことが重要ですが、人間の目や手の代わりに機械を使用することで、実際の染色プロセスを理解する能力が損なわれる可能性があります。
世界のスライドステイナー市場は、ポーターのファイブフォース分析、サプライチェーン分析、規制分析、価格分析、償還分析、アンメットニーズなど、様々な業界要因に基づいた市場の詳細な分析を提供しています。
COVID-19の影響分析
COVID-19のパンデミックは、人々、地域社会、企業に深刻な影響を与えながら日々展開し続けています。いくつかの産業の成長に大きな影響を与える一方で、他の多くの市場は無傷で残り、有望な成長機会を示す可能性があります。利害関係者がCOVID-19に感染した患者の診断と治療に向けて新しいアプローチをますます探しているので、世界のスライドステイナー市場はCOVID-19の流行から大きな弾みを受けています。
研究開発の増加は、いくつかの製薬会社やバイオテクノロジー企業によって実施されています。したがって、臨床研究の需要の増加は、スライドステイナーメーカーにいくつかの機会を生成することが期待され、それゆえ、予測期間にわたって市場の成長を後押しすることが期待されます。新型コロナウイルスの劇的な爆発は、世界的に生命に影響を与えています。病院や研究所は信頼性の高いCOVID-19検査キットへのアクセスを必要としており、COVID-19の拡散防止に取り組む最前線の医療専門家を支援する企業が複数現れています。診断テストまたは分子テストは、人が活動性のSARS-CoV-2感染症にかかっているかどうかに答えるものです。一方、血清学的検査や抗体検査は、人の血液中にCOVID-19に対する抗体があるかどうかを調べることで、その人がCOVID-19に感染していたかどうかを明らかにします。100種類以上のCOVID-19診断検査が緊急時使用承認(EUA)を取得しています。
The global slide stainer market size was valued at US$ 3704.2 million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 11% during the forecast period (2022-2029).
A stainer is used to separate tissues or cells, to carry microscopic study and identification. A slide stainer automates the staining of prepared cytology or histology tissue specimens by diffusing dyes into the samples through direct or indirect staining, surface adsorption, or mordant staining. An automated slide stainer uses two processes, rotating transport and linear transport.
The global slide stainer market growth is driven rising prevalence of chronic and infectious diseases, technological advancements, and growing demand for automation in diagnostics and clinical research are among the key factors driving the market growth.
The increasing prevalence of chronic diseases is expected to drive growth in the forecast period
The growing prevalence of chronic and life-threatening diseases is driving pharmaceutical companies and research firms to focus on R&D activities to develop effective therapeutics. Strides made in lab instrumentation automation have led to the application of slide stainers in disease diagnosis and oncology research.
As per the International Diabetes Federation, diabetes patients spent US$ 760 billion in 2019, of which, most was spent by Type-1 diabetes patients on insulin drugs. Around 463 million adults (20-79 years) are living with diabetes currently, and by 2045 this is projected to rise to 700 million. The proportion of type 2 diabetes people is increasing in most countries. Also, as per the American Heart Association, in 2015, approximately 41.5% of the U.S. population was suffering from some form of cardiac disease, it is further estimated that this prevalence is likely to increase to 45% by 2035. According to the Centers for Disease Control and Prevention (CDC) of the U.S., about half of the population (47%) of the United States have at least one of these three risk factors. According to the National Cancer Institute, the most common cancers are prostate cancer, breast cancer, lung and bronchus cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, kidney and renal pelvis cancer, endometrial cancer, leukemia, pancreatic cancer, thyroid cancer, and liver cancer.
Hence, the growing health burden of chronic and infectious diseases is a major factor boosting the demand for slide stainers, especially in developed countries. In developing countries, the prevalence of infectious diseases has increased the spending of the population on regular health checkups, which has encouraged healthcare providers such as hospitals to automate lab processes. This has increased the demand for high-performing slide stainers.
Concerns associated with automated slide stainers are likely to hinder market growth
There are some concerns associated with the use of autostainers such as the initial expense, space availability, and repair issues, which are slow the adoption of slide stainers. A routine stainer may have only a manual method as a backup, but the stainer may be occupying the only space in the laboratory where a manual stain system can fit.
The downtime for repairs is lengthy if service technicians with lack of professional technicians in developing countries. Some technologists object to being limited to the dedicated reagents required by some systems.
Another concern is that the technologist is now removed from the staining process. When doing a manual stain, the technologist can observe each step; if he or she sees that something is wrong, the procedure can often be stopped to correct the problem.
A staining problem on an automated system may not be noticed until the finished product is reviewed, and sometimes troubleshooting at this stage is difficult. In training situations, learning the principles of staining is important, and the use of a machine instead of human eyes and hands may impair the trainee's ability to understand the actual process of staining.
The global slide stainer market provides in-depth analysis of the market based on various industry factors such as porter's five force analysis, supply chain analysis, regulatory analysis, pricing analysis, reimbursement analysis, unmet needs.
COVID-19 Impact Analysis
The COVID-19 pandemic continues to unfold everyday with severe impact on people, communities, and businesses. The growth in several industries are impacted significantly while numerous other markets may remain unscathed and show promising growth opportunities. The global slide stainer market has received immense impetus from the COVID-19 pandemic, as stakeholders are increasingly searching for newer approaches towards diagnosing and curing patients affected by the COVID-19.
Increasing research and development is being undertaken by several pharmaceutical and biotechnology companies. Thus, rising demand for clinical research is expected to generate several opportunities for the slide stainer manufacturers, hence, expected to boost the market growth over the forecast period. The dramatic explosion of the novel coronavirus is affecting lives globally. Hospitals and labs need access to reliable COVID-19 test kits, and several companies are coming up to support the medical professionals on the front lines working to prevent the spread of COVID-19. Diagnostic or molecular tests answer whether a person has active SARS-CoV-2 infection or not. In contrast, serological or antibody tests reveal if a person had COVID-19 by assaying for the presence of antibodies to COVID-19 in a person's blood. Over 100 COVID-19 diagnostic tests with Emergency Use Authorization (EUA).
The hematoxylin and eosin segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)
Hematoxylin and Eosin have been used for recognizing various tissue types and morphologic changes. Hematoxylin has deep blue to purple color and stain nuclei of the cells, against pink background counterstained by Eosin. Moreover, hematoxylin and eosin are the key ingredients in stains used by biological laboratories and pathologists. Hematoxylin is an excellent nuclear stain that is used widely in cytology and histology, two of the most important uses being as a nuclear stain in the Papanicolaou procedure for the diagnosis of vaginal cancer and in combination with the contrast stain Eosin, which is the chief diagnostic tool for most other cancers.
Rising demand for the hematoxylin and eosin for the various diagnostic test and laboratories uses is expected to fuel the growth of the segment over the forecast period. Moreover, increasing technological development such as the expansion of high throughput hematology analyzers and the introduction of basic cytometry techniques analyzers have been propelling segment growth and the trend is expected to continue over the forecast period.
However, intense competition among existing players and the high cost of hematoxylin and eosin are supposed to restrain the market in the forecast period. Also, time-consuming and stringent regulatory policies are projected to hamper market growth over the forecast period.
North America region holds the largest market share of the global slide stainer market
North America is anticipated to account for a major share of the global slide stainer market. This can be ascribed to the region leading in a wide array of diagnostic and research capabilities and in the adoption of automation for the same. Histological and cytological examinations are a routine part of diagnostics and drug discovery research, an arena in which North America are frontrunners. Key players operating in the global slide stainer market in the region are collaborating, partnership, acquisition and product launch, that will drive the growth of the market in the region.
For instance, in February 13, 2020, Biocare Medical LLC Launch of seven novel IVD IHC antibody markers for clinical diagnostics and research applications. The most recent launch focuses on several immuno-oncology markers, critical in aiding early-stage cancer drug developments and patient treatment.
Also, in the USA, favorable national regulatory mechanisms along with presence of large patient pool further accelerates overall business growth. Moreover, increasing use of dignostic services with enhanced support for research and ethics augments the demand for slide stainer in the region.
The slide stainer market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Agilent Technologies Inc., Danaher Corp., Sakura, BioGenex, Thermo Fisher Scientific, Biocare Medical, Merck Group, General Data Company, and Hardy Diagnostics, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the slide stainer market globally. For instance, in March 2020, ELITechGroup Inc. launched the Aerospray Cytology Slide Stainer Cytocentrifuge which automates the preparation and staining of liquid-based cytology specimens to facilitate the examination of an array of cell differentiations utilizing Papanicolaou staining techniques. The device performs two functions of sample preparation through cytocentrifugation and sample staining.
Sakura Finetek
Overview: Sakura Finetek, was founded in 1986 with the U.S. office based in Torrance, California. It is the global leader in continuous innovation for pathology by providing integrated solutions for anatomic pathology and patients through best-in-class innovation, quality, and customer care. Sakura Finetek is a leading industry in the development and commercialization of automated histology instrumentation and consumables for anatomic pathology. The company specializes in pathology, histology, smart automation, tissue processors, tissue embedders, H&E stainers, cover slippers - film & glass, advanced staining - IHC & ISH, microtomes, cassette & slide printers, blades, grossing, storage systems - blocks & slides, cryostats, digital microscopes, histopathology, cancer diagnostics, tissue-Tek, accu-edge, and histology consumables
Product Portfolio: Histo-Tek SL Slide Stainer: The Histo-Tek SL Slide Stainer is an automated slide stainer offering a new level of convenience and standardization for your low-volume laboratory needs, all at a low total cost of ownership.
The global slide stainer market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.
LIST NOT EXHAUSTIVE